Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

63-42-3
98123-83-2

File Name: pfizerah_com---ce.asp
                               MATERIAL SAFETY DATA SHEET

SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY

1-866-531-8896
Pfizer Inc Emergency telephone
24 Hours
Pfizer Animal Health Hours of operation
1-800-366-5288
235 East 42nd Street Telephone
New York, NY 10017
Trade names 庐
Cestex Tablets
Product name 庐
Cestex Tablets
Antihelmintic
Therapeutic use
Round, biconvex tablet
Description


SECTION 2 - COMPOSITION

Ingredient CAS Number Amount
Lactose 63-42-3 74%
Epsiprantel 98123-83-2 12%
Film coating Not assigned <5.0%
Non-hazardous ingredients Not applicable <15%
Note: Ingredient(s) indicated as hazardous have been assessed under standards
for workplace safety.


SECTION 3 - HAZARDS IDENTIFICATION

Not applicable
Signal word
Not applicable
Statements of hazard
Eye effects Not expected due to physical form. Dust may cause irritation.
Not expected to cause skin irritation.
Skin effects
Not expected due to physical form.
Inhalation effects
Ingestion effects Toxicity following ingestion is not expected.Ingestion should be avoided.
This document has been prepared in accordance with standards for
NOTE:
workplace safety, which require the inclusion of all known hazards of the
product or its ingredients regardless of the potential risk. The
precautionary statements and warnings included may not apply in all
cases. Your needs may vary depending upon the potential for exposure in
your workplace.




10000453 - Cestex庐 Tablets Pfizer Inc.
Revision date: 02/08/94, Version: 1.0.0 Page 1 of 5
SECTION 4 - FIRST AID MEASURES

Remove contaminated clothing and remaining material by flushing with
Skin
water. Obtain medical assistance if immediate or delayed symptoms of
skin reaction develop.
Eyes Immediately flush eyes with water for at least 15 minutes. If irritation
occurs or persists, get medical attention.
Inhalation Remove to fresh air. If not breathing, give artificial respiration. If
discomfort persists, get medical attention.
In the event of swallowing this material, seek medical assistance.
Ingestion


SECTION 5 - FIRE FIGHTING MEASURES

This mixture is non flammable but may support combustion.
General hazard
Wear approved positive pressure, self-contained breathing apparatus and
Fire fighting instructions
full protective turn out gear. Move containers from fire area if possible
without increased personal risk. Dike area if possible to contain water for
later disposal.
Use water, carbon dioxide, foam or dry chemical extinguishers.
Extinguishing media
Expected to be >55掳C
Flash point
Toxic or corrosive gases are expected in fires involving this mixture.
Hazardous combustion
products


SECTION 6 - ACCIDENTAL RELEASE MEASURES

Review Sections 3, 8 and 12 before proceeding with clean up.
General
Small spill Sweep spilled material into an approved container for disposal. Clean spill
area thoroughly.
Large spill Contain the source of the spill or leak if it is safe to do so. Scoop or shovel
spilled material into a labeled container for disposal. Clean spill area
thoroughly.


SECTION 7 - HANDLING AND STORAGE

IF TABLETS OR CAPSULES ARE CRUSHED AND/OR BROKEN,
General handling
AVOID BREATHING DUST AND AVOID CONTACT WITH EYES,
SKIN AND CLOTHING.
Avoid prolonged storage at elevated temperatures (greater than room
Storage conditions
temperature, approximately 20 degrees C). Keep in tightly closed
containers or packages away from moisture.

10000453 - Cestex庐 Tablets Pfizer Inc.
Revision date: 02/08/94, Version: 1.0.0 Page 2 of 5
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION

Good general ventilation should be sufficient to control airborne levels.
Ventilation
Respirators are not required for the normal use of this mixture.
Respiratory protection
Wear eye protection if eye contact is possible.
Eye protection
Wear protective clothing with long sleeves to avoid skin contact. Wash
Skin protection
hands and arms thoroughly after handling this mixture.
Wear protective gloves to avoid repeated skin contact.
Hand protection


SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES

Tablet
Physical form
No data available
Color
Mixture
Molecular weight
Mixture
Molecular formula
Not applicable
pH
Not applicable
Boiling point
No data available
Melting point
No data available
Density
No data available
Vapor pressure
Soluble
Water solubility
No data available
Solvent solubility


SECTION 10 - STABILITY AND REACTIVITY

Stable
Reactivity
Direct sunlight, conditions that might generate heat and dispersion as a
Conditions to avoid
dust cloud
None identified
Incompatibilities
None under normal conditions
Hazardous
decomposition
products
Not expected to occur
Hazardous
polymerization




10000453 - Cestex庐 Tablets Pfizer Inc.
Revision date: 02/08/94, Version: 1.0.0 Page 3 of 5
SECTION 11 - TOXICOLOGY INFORMATION

Acute toxicity
Compound Type Route Species Dosage
Lactose LD 50 Oral Rat >10,000 mg/kg
Eye Not determined for this mixture. Dust may cause irritation.
Skin Not determined for this mixture. Not expected to cause skin irritation.
Not determined for this mixture.
Inhalation
The calculated oral LD50 is greater than 2000 mg/kg in rats, based on
Ingestion
toxicities of individual components and concentrations present.
This mixture is not expected to be mutagenic, based on effects of
Mutagenicity
individual components.
Not determined for this mixture.
Subchronic effects
Not determined for this mixture.
Chronic effects/
carcinogenicity
None of the components of this formulation is listed as a carcinogen by
Carcinogen status
IARC, NTP or OSHA.
Not determined for this mixture. No components in this mixture are
Reproductive effects
expected to produce adverse effects on male or female reproduction under
occupational conditions.
Not determined for this mixture. No components in this mixture are
Teratogenicity
expected to produce adverse effects on developing offspring under
occupational conditions.
None known.
At increased risk from
exposure
This mixture contains a material that is an anthelminthic in animals.
Additional information


SECTION 12 - ECOLOGICAL INFORMATION

The environmental characteristics of this mixture have not been fully
Environmental overview
evaluated. Releases to the environment should be avoided.


SECTION 13 - DISPOSAL INFORMATION

Collect for recycling or recovery, if possible. Observe all local and
Disposal procedure
national regulations when disposing of this material. Dispose of material
on site in a licensed chemical incinerator, if allowed by the incinerator
permit. If no on-site incinerator is available, dispose of material in a
licensed commercial chemical incinerator.


10000453 - Cestex庐 Tablets Pfizer Inc.
Revision date: 02/08/94, Version: 1.0.0 Page 4 of 5
SECTION 14 - TRANSPORTATION INFORMATION

Not regulated for transport under USDOT, EUADR, IATA, or IMDG
General shipping
regulations.
instructions


SECTION 15 - REGULATORY INFORMATION

Not classified
EU Classification
This product has been classified in accordance with the hazard criteria of
Canadian WHMIS
the CPR and the MSDS contains all of the information required by the
CPR.


SECTION 16 - OTHER

Disclaimer Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate, and while it is provided in good faith, it
is without a warranty of any kind, expressed or implied.




10000453 - Cestex庐 Tablets Pfizer Inc.
Revision date: 02/08/94, Version: 1.0.0 Page 5 of 5

Search    ENTER KEYWORD
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
pfizerah_com---bh.asp 57-50-1 9000-70-8 1403-66-3 1406-05-9 57-92-1
pfizerah_com---bi.asp 1403-66-3 7732-18-5
pfizerah_com---bp.asp 1403-66-3 54-64-8 7732-18-5
pfizerah_com---cd.asp 61336-70-7
pfizerah_com---ce.asp 63-42-3 98123-83-2
pfizerah_com---cg.asp 57-50-1 57-92-1 1406-05-9
pfizerah_com---ck.asp 1403-66-3 54-64-8 21645-51-2 7732-18-5
pfizerah_com---convenia_displaymsds.asp N/A
pfizerah_com---ct.asp 61336-70-7
pfizerah_com---cv.asp 7732-18-5 1722-62-9
pfizerah_com---dc.asp 65-85-0 6915-15-7 99-76-3 57-55-6 94-13-3 69-72-2 112-92-5 9005-00-9 11138-66-2
pfizerah_com---dd.asp N/A
pfizerah_com---de.asp 21645-51-2 1403-66-3 54-64-8 7732-18-5
pfizerah_com---dm.asp 7732-18-5
pfizerah_com---do.asp 94-13-3 99-76-3 86347-15-1 7647-14-5 7732-18-5
pfizerah_com---ds.asp 90038-01-0 7647-14-5 99-76-3 7732-18-5
pfizerah_com---dt.asp 117704-25-3 108-95-2 111-62-6 8008-74-0
pfizerah_com---dx.asp 872-50-4
pfizerah_com---ee.asp 70288-86-7 70161-11-4 70209-81-3
pfizerah_com---eh.asp 144-55-8 56-40-6 7447-90-7 50-99-7
pfizerah_com---eq.asp 55268-74-1 70288-86-7 70161-11-4 70209-81-3
pfizerah_com---f2.asp 1403-66-3 7732-18-5
pfizerah_com---f3.asp 1403-66-3 7732-18-5
pfizerah_com---f4.asp 1403-66-3 7732-18-5
pfizerah_com---f5.asp N/A
pfizerah_com---fd.asp 1406-05-9 57-92-1 7732-18-5
pfizerah_com---fl.asp 1403-66-3 7732-18-5
pfizerah_com---fm.asp 1403-66-3 57-50-1 9000-70-8
pfizerah_com---l9.asp 7732-18-5 64058-48-6 859-18-7
pfizerah_com---la.asp 57-50-1 7732-18-5
pfizerah_com---lc.asp 7732-18-5 859-18-7
pfizerah_com---le.asp 7732-18-5
pfizerah_com---m2.asp 9005-25-8
pfizerah_com---m5.asp 57-55-6 2919-66-6
pfizerah_com---mc.asp 8003-34-7 51-03-6 113-48-4 136-45-8
pfizerah_com---mi.asp 1330-20-7
pfizerah_com---nc.asp 50-99-7 7723-14-0
pfizerah_com---nt.asp N/A
pfizerah_com---oc.asp 6915-15-7 65-85-0 69-72-2 57-55-6
pfizerah_com---pb.asp N/A
pfizerah_com---pc.asp 57-50-1 7732-18-5
pfizerah_com---pe.asp N/A
pfizerah_com---pn.asp N/A
pfizerah_com---pp.asp 57-50-1 9000-70-8 1403-66-3
pfizerah_com---pt.asp N/A
pfizerah_com---px.asp 7732-18-5 25322-68-3
pfizerah_com---r1.asp 54-64-8 9005-65-6 1338-43-8 8042-47-5
pfizerah_com---rb.asp 77-92-9 50-99-7 56-40-6 7778-49-6 7778-77-0 7647-14-5
pfizerah_com---rf.asp 60-00-4 1403-66-3 54-64-8 7732-18-5
pfizerah_com---rh.asp 57-50-1 9000-70-8 1406-05-9 57-92-1 1403-66-3

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com | Ads link:HBCCHEM.INC